Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
21.69
-0.32 (-1.45%)
Mar 28, 2025, 4:00 PM EDT - Market closed
IART Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for IART stock have an average target of 24.67, with a low estimate of 18 and a high estimate of 35. The average target predicts an increase of 13.74% from the current stock price of 21.69.
Analyst Consensus: Sell
* Price targets were last updated on Feb 26, 2025.
Analyst Ratings
The average analyst rating for IART stock from 7 stock analysts is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 9 | 9 | 9 | 9 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $35 | Buy | Reiterates | $35 | +61.36% | Feb 26, 2025 |
| Citigroup | Citigroup | Strong Sell Maintains $16 → $22 | Strong Sell | Maintains | $16 → $22 | +1.43% | Nov 5, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $26 → $21 | Hold | Maintains | $26 → $21 | -3.18% | Oct 14, 2024 |
| B of A Securities | B of A Securities | Sell Maintains $26 → $18 | Sell | Maintains | $26 → $18 | -17.01% | Oct 7, 2024 |
| BTIG | BTIG | Strong Sell → Hold Upgrades n/a | Strong Sell → Hold | Upgrades | n/a | n/a | Oct 7, 2024 |
Financial Forecast
Revenue This Year
1.72B
from 1.61B
Increased by 6.49%
Revenue Next Year
1.79B
from 1.72B
Increased by 4.49%
EPS This Year
2.56
from -0.09
EPS Next Year
2.84
from 2.56
Increased by 10.59%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.8B | 1.9B | 1.9B |
| Avg | 1.7B | 1.8B | 1.9B |
| Low | 1.6B | 1.7B | 1.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 10.8% | 10.1% | 7.8% |
| Avg | 6.5% | 4.5% | 3.7% |
| Low | 1.6% | -1.5% | -1.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 2.76 | 3.16 | 3.55 |
| Avg | 2.56 | 2.84 | 3.45 |
| Low | 2.37 | 2.61 | 3.31 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 23.3% | 25.2% |
| Avg | - | 10.6% | 21.6% |
| Low | - | 1.7% | 16.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.